Cargando…
“Trained immunity” from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes
Protective variables for Coronavirus Disease 2019 (COVID-19) are unknown. “Trained immunity” of the populace as a result of Bacille Calmette–Guérin (BCG) vaccination policy implementation and coverage had been suggested to be one of the factors responsible for the differential impact of COVID-19 on...
Autores principales: | Singh, Samer, Maurya, Rajendra Prakash, Singh, Rakesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595322/ https://www.ncbi.nlm.nih.gov/pubmed/33119725 http://dx.doi.org/10.1371/journal.ppat.1008969 |
Ejemplares similares
-
“Trained Immunity” from Mycobacterium spp. exposure (BCG vaccination and environmental) may have an impact on the incidence of early childhood leukemia
por: Singh, Samer, et al.
Publicado: (2023) -
Higher BCG‐induced trained immunity prevalence predicts protection from COVID‐19: Implications for ongoing BCG trials
por: Singh, Samer, et al.
Publicado: (2022) -
Is the BCG Vaccine an Answer to Future Pandemic Preparedness?
por: Khan, Nadia H., et al.
Publicado: (2022) -
BCG vaccination policy, natural boosting and pediatric brain and CNS tumor incidences
por: Singh, Samer, et al.
Publicado: (2023) -
Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
por: Gunasena, Manuja, et al.
Publicado: (2022)